Critical Care of Traumatic Spinal Cord Injury

被引：52

作者：

Jia, Xiaofeng ^{[1
,2
]}

Kowalski, Robert G. ^{[3
,4
]}

Sciubba, Daniel M. ^{[4
,5
,6
]}

Geocadin, Romergryko G. ^{[3
,4
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA

[2] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA

[3] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA

[4] Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosurg, Baltimore, MD 21205 USA

[5] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA

[6] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA

来源：

JOURNAL OF INTENSIVE CARE MEDICINE | 2013年 / 28卷 / 01期

关键词：

spinal cord injury; critical care; treatment; SCI; URINARY-TRACT-INFECTION; POST-CARDIAC ARREST; VENA-CAVA FILTERS; SYSTEMIC HYPOTHERMIA; COMPRESSION INJURY; BLADDER MANAGEMENT; STEM-CELLS; RESPIRATORY COMPLICATIONS; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA;

D O I：

10.1177/0885066611403270

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Approximately 11 000 people suffer traumatic spinal cord injury (TSCI) in the United States, each year. TSCI incidences vary from 13.1 to 52.2 per million people and the mortality rates ranged from 3.1 to 17.5 per million people. This review examines the critical care of TSCI. The discussion will focus on primary and secondary mechanisms of injury, spine stabilization and immobilization, surgery, intensive care management, airway and respiratory management, cardiovascular complication management, venous thromboembolism, nutrition and glucose control, infection management, pressure ulcers and early rehabilitation, pharmacologic cord protection, and evolving treatment options including the use of pluripotent stem cells and hypothermia.

引用

页码：12 / 23

页数：12

共 163 条

[11] A RANDOMIZED, CONTROLLED TRIAL OF METHYLPREDNISOLONE OR NALOXONE IN THE TREATMENT OF ACUTE SPINAL-CORD INJURY - RESULTS OF THE 2ND NATIONAL ACUTE SPINAL-CORD INJURY STUDY [J].